A5073133784- Biosimilars and Bioanalytical Methods
- Pregnancy and Medication Impact
- COVID-19 Impact on Reproduction
- Reproductive System and Pregnancy
- COVID-19 and healthcare impacts
- Child and Adolescent Health
- Health Systems, Economic Evaluations, Quality of Life
- Long-Term Effects of COVID-19
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Shoulder Injury and Treatment
- Elbow and Forearm Trauma Treatment
- Child Abuse and Trauma
- Adolescent and Pediatric Healthcare
- Pharmaceutical Economics and Policy
- Autoimmune and Inflammatory Disorders Research
- Health, psychology, and well-being
- Ethics and Legal Issues in Pediatric Healthcare
- Microscopic Colitis
- Musculoskeletal synovial abnormalities and treatments
- Monoclonal and Polyclonal Antibodies Research
Georgetown University Medical Center
2015-2022
Georgetown University
2008-2022
Arthritis and Rheumatism Associates
2018-2022
An important challenge currently facing rheumatologists and rheumatology health professionals is to gain an understanding of the landscape surrounding biosimilar agents, including scientific, clinical, economic, prescribing issues related their use. The US Food Drug Administration (FDA) defines a as biologic product that "highly similar to" approved (the "reference," "originator," or "bio-originator" product) has "no clinically meaningful differences" in safety effectiveness compared...
To describe coronavirus disease 2019 (COVID-19) and pregnancy outcomes in patients with rheumatic who were pregnant at the time of infection.Since March 2020, COVID-19 Global Rheumatology Alliance has collected cases COVID-19. We report details women infection, including obstetric separately ascertained from providers.We on 39 patients, 22 detail available. The mean median age was 33 years, range 24-45 years. Rheumatic diagnoses included rheumatoid arthritis (n = 9), systemic lupus...
To describe obstetric outcomes based on COVID-19 vaccination status, in women with rheumatic and musculoskeletal diseases (RMDs) who developed during pregnancy.
Objective To evaluate the utility of a web‐based advocacy training tool in increasing awareness. Methods Early career rheumatologists who attended 2019 American College Rheumatology Advocacy 101 were invited to participate. A consisting 9 cases covering various aspects was developed and included opportunity for continuing medical education credit. preparticipation questionnaire surveyed prior involvement, knowledge, willingness participate an program. Participants rated based on educational...